Findings challenge prevailing ignition–sustainment assumptions, reframing plasma instability as a systems-level ...

We designed the platform so business leaders and their teams can think clearly, act decisively, and stay accountable ...

Can positive anticipation that activates the brain’s reward system strengthen the body’s immune defenses? A new study by Tel Aviv University, the Technion, and Tel Aviv Medical Center (Ichilov), ...

As Bangladesh navigates its next decades, the country faces critical choices in governance, electoral credibility, and civic engagement. From historical legacies to generational change, institutional ...

COVID-19-associated thrombotic microangiopathy has emerged as a severe complication that exacerbates morbidity and mortality in critical cases. Thrombotic microangiopathy, characterized by ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

FDA approval enables Complement Therapeutics to start the Opti-GAIN phase 1/2 trial for CTx001 in GA secondary to AMD. CTx001 is an AAV-based gene therapy delivering a truncated Complement Receptor 1 ...

The video shows how our lymphatic system works undercover to protect our immune system. The network transports about two liters of lymphatic fluid throughout the body, identifies pathogens, trains ...

Kawasaki Disease (KD) is an acute febrile systemic vasculitis of unknown etiology and the leading cause of acquired heart disease among children. The complement system is a major component of innate ...

BioWorld - Thursday, June 19, 2025 Breaking News: Trump administration impacts continue to roil the life sciences sector See today's BioWorld Science Home » CTX-114 enhances surface binding and ...